SCHEDULE 13D

Company

BIOXYTRAN, INC

Filed

September 18, 2018

Accession Number

0001213900-18-012668

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →